Susan E Andrade

Summary

Affiliation: Meyers Primary Care Institute
Country: USA

Publications

  1. pmc Validity of health plan and birth certificate data for pregnancy research
    Susan E Andrade
    Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
    Pharmacoepidemiol Drug Saf 22:7-15. 2013
  2. pmc Medication Exposure in Pregnancy Risk Evaluation Program
    Susan E Andrade
    Meyers Primary Care Institute, 630 Plantation St, Worcester, MA 01605, USA
    Matern Child Health J 16:1349-54. 2012
  3. ncbi request reprint Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis
    Susan E Andrade
    Meyers Primary Care Institute Fallon Foundation and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA 01605, USA
    J Clin Epidemiol 58:171-4. 2005
  4. ncbi request reprint Methods for evaluation of medication adherence and persistence using automated databases
    Susan E Andrade
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:565-74; discussion 575-7. 2006
  5. ncbi request reprint Use of prescription medications with a potential for fetal harm among pregnant women
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:546-54. 2006
  6. ncbi request reprint Use of antidepressant medications during pregnancy: a multisite study
    Susan E Andrade
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    Am J Obstet Gynecol 198:194.e1-5. 2008
  7. doi request reprint Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
    Susan E Andrade
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 18:246-52. 2009
  8. doi request reprint Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy
    Susan E Andrade
    Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
    Pharmacoepidemiol Drug Saf 20:1168-76. 2011
  9. doi request reprint Outpatient use of cardiovascular drugs during pregnancy
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 17:240-7. 2008
  10. ncbi request reprint Prescription drug use in pregnancy
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
    Am J Obstet Gynecol 191:398-407. 2004

Collaborators

Detail Information

Publications58

  1. pmc Validity of health plan and birth certificate data for pregnancy research
    Susan E Andrade
    Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
    Pharmacoepidemiol Drug Saf 22:7-15. 2013
    ..To evaluate the validity of health plan and birth certificate data for pregnancy research...
  2. pmc Medication Exposure in Pregnancy Risk Evaluation Program
    Susan E Andrade
    Meyers Primary Care Institute, 630 Plantation St, Worcester, MA 01605, USA
    Matern Child Health J 16:1349-54. 2012
    ..This partnership combines clinical and research expertise and data resources to enable the evaluation of outcomes associated with medication use during pregnancy...
  3. ncbi request reprint Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis
    Susan E Andrade
    Meyers Primary Care Institute Fallon Foundation and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA 01605, USA
    J Clin Epidemiol 58:171-4. 2005
    ....
  4. ncbi request reprint Methods for evaluation of medication adherence and persistence using automated databases
    Susan E Andrade
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:565-74; discussion 575-7. 2006
    ..Our aim was to perform a systematic review of the methods currently being used to assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic studies using automated databases...
  5. ncbi request reprint Use of prescription medications with a potential for fetal harm among pregnant women
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:546-54. 2006
    ..To estimate the prevalence of use of prescription drugs with a potential for fetal harm among pregnant women in the United States...
  6. ncbi request reprint Use of antidepressant medications during pregnancy: a multisite study
    Susan E Andrade
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    Am J Obstet Gynecol 198:194.e1-5. 2008
    ..This study was undertaken to provide information on the prevalence of use of antidepressant drugs among pregnant women in the United States...
  7. doi request reprint Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
    Susan E Andrade
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 18:246-52. 2009
    ....
  8. doi request reprint Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy
    Susan E Andrade
    Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester, MA, USA
    Pharmacoepidemiol Drug Saf 20:1168-76. 2011
    ..To evaluate the validity of health plan administrative and claims data to identify pre-gestational and gestational diabetes, obesity, and ultrasounds among pregnant women...
  9. doi request reprint Outpatient use of cardiovascular drugs during pregnancy
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 17:240-7. 2008
    ..To provide information on the prevalence of use of cardiovascular drugs, some of which may have fetotoxic or teratogenic effects, in the outpatient setting among pregnant women in the United States...
  10. ncbi request reprint Prescription drug use in pregnancy
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
    Am J Obstet Gynecol 191:398-407. 2004
    ..The purpose of this study was to provide information on the prevalence of the use of prescription drugs among pregnant women in the United States...
  11. doi request reprint Antipsychotic medication use among children and risk of diabetes mellitus
    Susan E Andrade
    Meyers Primary Care Institute, University of Massachusetts, Worcester, MA 01605, USA
    Pediatrics 128:1135-41. 2011
    ..To assess whether the risk of incident diabetes was increased with the use of second-generation antipsychotics (SGAs) in a large diverse cohort of children...
  12. pmc A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
    Susan E Andrade
    Meyers Primary Care Institute Reliant Medical Group, Fallon Community Health Plan, and University of Massachusetts Medical School, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 21:100-28. 2012
    ..To perform a systematic review of the validity of algorithms for identifying cerebrovascular accidents (CVAs) or transient ischemic attacks (TIAs) using administrative and claims data...
  13. pmc The dynamics of chronic gout treatment: medication gaps and return to therapy
    Leslie R Harrold
    Meyers Primary Care Institute, Worcester, Mass, USA
    Am J Med 123:54-9. 2010
    ..To identify gaps in therapy with urate-lowering drugs for the treatment of gout as well as factors associated with resuming therapy...
  14. pmc Validation of an algorithm to estimate gestational age in electronic health plan databases
    Qian Li
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 22:524-32. 2013
    ..To validate an algorithm that uses delivery date and diagnosis codes to define gestational age at birth in electronic health plan databases...
  15. pmc A systematic review of validated methods for identifying heart failure using administrative data
    Jane S Saczynski
    Division of Geriatric Medicine and Meyers Primary Care Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 21:129-40. 2012
    ..To identify and describe the validity of algorithms used to detect heart failure (HF) using administrative and claims data sources...
  16. pmc Comparison of drug adherence rates among patients with seven different medical conditions
    Becky A Briesacher
    Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts Meyers Primary Care Institute, Worcester, MA 01605, USA
    Pharmacotherapy 28:437-43. 2008
    ..To compare drug adherence rates among patients with gout, hypercholesterolemia, hypertension, hypothyroidism, osteoporosis, seizure disorders, and type 2 diabetes mellitus by using a standardized approach...
  17. ncbi request reprint Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective
    Leslie R Harrold
    Meyers Primary Care Institute, University of Massachusetts Medical School and Fallon Foundation, Worcester, MA 01655, USA
    J Rheumatol 32:1076-80. 2005
    ..To estimate the incidence of Churg-Strauss syndrome (CSS) among a large population of asthma drug users...
  18. ncbi request reprint Early detection of adverse drug events within population-based health networks: application of sequential testing methods
    Jeffrey S Brown
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 16:1275-84. 2007
    ....
  19. ncbi request reprint Asthma drug use and the development of Churg-Strauss syndrome (CSS)
    Leslie R Harrold
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic and Fallon Community Health Plan, Worcester, MA 01655, USA
    Pharmacoepidemiol Drug Saf 16:620-6. 2007
    ..Using pooled data from two nested case-control studies, we examined the association between asthma drug use and the development of CSS...
  20. ncbi request reprint Validity of gout diagnoses in administrative data
    Leslie R Harrold
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, Massachusetts 01655, USA
    Arthritis Rheum 57:103-8. 2007
    ..To determine the utility of using administrative data for epidemiologic studies of gout by examining the validity of gout diagnoses in claims data...
  21. doi request reprint Administrative data used to identify patients with irritable bowel syndrome
    Sarah L Goff
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA 01605, USA
    J Clin Epidemiol 61:617-21. 2008
    ..To assess the usefulness of health plan administrative data for identifying patients with irritable bowel syndrome (IBS)...
  22. pmc Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries
    Sengwee Toh
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    Arch Womens Ment Health 16:149-57. 2013
    ..Studies are needed to examine the comparative safety and effectiveness of these medications relative to other therapeutic options in pregnancy...
  23. pmc Adherence with urate-lowering therapies for the treatment of gout
    Leslie R Harrold
    Department of Medicine, The Meyers Primary Care Institute, Worcester, MA 01605, USA
    Arthritis Res Ther 11:R46. 2009
    ..Adherence to urate-lowering drugs (ULDs) has not been well evaluated among those with gout. Our aim was to assess the level and determinants of non-adherence with ULDs prescribed for gout...
  24. pmc Adoption of once-monthly oral bisphosphonates and the impact on adherence
    Becky A Briesacher
    University of Massachusetts Medical School, Meyers Primary Care Institute, and Fallon Clinic, Worcester, MA 01605, USA
    Am J Med 123:275-80. 2010
    ..The extent of the adoption of once-monthly bisphosphonates into general clinical practice is not known, nor is it known if the novel formulation improves adherence...
  25. doi request reprint Bone density consequences of initiation and compliance with therapy for osteoporosis
    Robert A Yood
    Fallon Clinic and Meyers Primary Care Institute, Worcester, Massachusetts 01605, USA
    Arthritis Care Res (Hoboken) 62:1440-5. 2010
    ..We sought to determine the bone density consequences of the decision to initiate and comply with therapy for OP...
  26. pmc Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates
    Becky A Briesacher
    Meyers Primary Care Institute, Fallon Clinic and the Fallon Community Health Plan Worcester, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
    Pharmacoepidemiol Drug Saf 19:1233-40. 2010
    ..The study aim is to test whether switching from once-weekly BPs to once-monthly BPs improves adherence and fracture risk...
  27. ncbi request reprint Low frequency of treatment of osteoporosis among postmenopausal women following a fracture
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
    Arch Intern Med 163:2052-7. 2003
    ..Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk of fracture, particularly for postmenopausal women with a history of fracture...
  28. ncbi request reprint Challenges of estimating health service utilization for osteoarthritis patients on a population level
    Leslie R Harrold
    Meyers Primary Care Institute, Fallon Healthcare System and University of Massachusetts Medical School, Worcester 01605, USA
    J Rheumatol 29:1931-6. 2002
    ....
  29. pmc Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs
    Robert A Yood
    Fallon Clinic, Worcester, MA 01605, USA
    J Gen Intern Med 23:1815-21. 2008
    ..There are effective treatments to prevent osteoporotic fractures, but these treatments are underutilized...
  30. pmc Medication adherence and use of generic drug therapies
    Becky A Briesacher
    Division of Geriatric Medicine, University of Massachusetts, Worcester, MA 01605, USA
    Am J Manag Care 15:450-6. 2009
    ..To assess whether lower copayments charged for generic drugs explain the improved drug adherence associated with use of generics...
  31. ncbi request reprint Consequences of poor compliance with bisphosphonates
    Becky A Briesacher
    University of Massachusetts Medical School, Division of Geriatric Medicine, Biotech Four, Worcester, MA 01605, USA
    Bone 41:882-7. 2007
    ..This study was undertaken to assess rates of osteoporotic fractures and health care utilization as a function of bisphosphonate compliance in usual clinical practice...
  32. ncbi request reprint Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States
    Christopher J Stille
    HMO Research Network Center for Education and Research on Therapeutics, University of Massachusetts Medical School, Worcester, MA 01655, USA
    Pediatrics 114:1206-11. 2004
    ....
  33. pmc A critical review of methods to evaluate the impact of FDA regulatory actions
    Becky A Briesacher
    Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 22:986-94. 2013
    ..To conduct a synthesis of the literature on methods to evaluate the impacts of FDA regulatory actions and identify best practices for future evaluations...
  34. ncbi request reprint Identification of patients with Churg-Strauss syndrome (CSS) using automated data
    Leslie R Harrold
    Meyers Primary Care Institute, The University of Massachusetts Medical School and the Fallon Healthcare System, Worcester, MA 01655, USA
    Pharmacoepidemiol Drug Saf 13:661-7. 2004
    ..Our aim was to identify individuals with Churg-Strauss syndrome (CSS) among asthma drug users, based on patterns of diagnostic and procedural codes (termed 'algorithms') contained in automated claims data...
  35. ncbi request reprint Hypertension management: the care gap between clinical guidelines and clinical practice
    Susan E Andrade
    Meyers Primary Care Institute, Fallon Foundation, and University of Massachusetts Medical School, Worcester, Mass 01605, USA
    Am J Manag Care 10:481-6. 2004
    ..To evaluate how well hypertension is managed in HMO patients and to assess opportunities for improvement...
  36. doi request reprint Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study
    Kathleen M Mazor
    Meyers Primary Care Institute, Worcester, Massachusetts, USA
    Drugs Aging 27:999-1008. 2010
    ..Osteoporosis is a significant health problem, especially for older women. Prescription osteoporosis medication can reduce fractures, but many women do not accept treatment or discontinue treatment before benefits are achieved...
  37. ncbi request reprint Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
    J Clin Epidemiol 55:310-3. 2002
    ..This study, using data from a large number of health plans located in different geographical regions, underscores the importance of evaluating the accuracy of the diagnoses from automated health plan databases...
  38. ncbi request reprint Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System, Worcester, Massachusetts 01605, USA
    J Am Geriatr Soc 50:178-81. 2002
    ..The vast majority of older people choosing less-comprehensive drug benefit plans appeared to make appropriate choices of plans based upon past utilization of prescription and other medical services...
  39. ncbi request reprint Communicating safety information to physicians: an examination of dear doctor letters
    Kathleen M Mazor
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 14:869-75. 2005
    ..This study examined whether content, organization, and formatting of dear doctor letters (DDLs) influences physicians' responses to the letters...
  40. ncbi request reprint Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control
    Cynthia J Willey
    Meyers Primary Care Institute, 630 Plantation Street, Worcester, MA 01605, USA
    Am J Manag Care 12:435-40. 2006
    ..To evaluate antidiabetic drug treatment patterns and glycemic control among patients diagnosed with type 2 diabetes mellitus...
  41. pmc Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature
    Leslie R Harrold
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, MA, USA
    Semin Arthritis Rheum 38:396-402. 2009
    ..Our aim was to perform a systematic review of the literature examining adherence with treatments for inflammatory rheumatic conditions to assess the magnitude of the problem in this patient population...
  42. ncbi request reprint Risk factors for statin-associated rhabdomyolysis
    Stephanie Schech
    Center for Health Care Policy and Evaluation, Eden Prairie, MN 55344, USA
    Pharmacoepidemiol Drug Saf 16:352-8. 2007
    ..To identify and characterize risk factors for rhabdomyolysis in patients prescribed statin monotherapy or statin plus fibrate therapy...
  43. ncbi request reprint Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001
    Steven R Simon
    HMO Research Network, Center for Education and Research on Therapeutics, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Massachusetts 02215, USA
    J Am Geriatr Soc 53:227-32. 2005
    ..To determine rates of potentially inappropriate medication use in elderly persons in managed care plans in the United States in 2000-2001...
  44. ncbi request reprint Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data
    Marsha A Raebel
    HMO Research Network, Center for Education and Research on Therapeutics CERTs, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 14:829-36. 2005
    ..Our aim was to evaluate the 270-day gestational age and delivery date assumptions used in an administrative dataset study assessing prenatal drug exposure compared to information contained in a birth registry...
  45. ncbi request reprint Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients
    Susan M Abughosh
    Pharmacoepidemiology and Pharmacoeconomics Program, University of Rhode Island, Kingston, Rhode Island 02881, USA
    J Manag Care Pharm 10:404-11. 2004
    ..To determine the effects of lipid-lowering agent (LLA) class and drug plan design option on persistence with LLAs among elderly patients enrolled in a managed care plan...
  46. ncbi request reprint Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Inflamm Bowel Dis 13:451-61. 2007
    ..There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities...
  47. ncbi request reprint Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 16:55-64. 2007
    ..The purpose of this retrospective cohort study was to assess creatinine and potassium monitoring and characteristics associated with monitoring among patients dispensed ACEi or ARB...
  48. ncbi request reprint Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
    David J Graham
    Office of of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA
    JAMA 292:2585-90. 2004
    ..Lipid-lowering agents are widely prescribed in the United States. Reliable estimates of rhabdomyolysis risk with various lipid-lowering agents are not available...
  49. ncbi request reprint Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)
    Stephen J Kogut
    Program in Pharmacoepidemiology and Pharmacoeconomics, University of Rhode Island, Kingston, RI, USA
    Pharmacoepidemiol Drug Saf 13:591-8. 2004
    ..To determine if nonadherence with antidiabetic drug therapy is predictive of subsequent antidiabetic drug therapy intensification...
  50. pmc Laboratory monitoring of drugs at initiation of therapy in ambulatory care
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit, Denver, CO 80237 8066, USA
    J Gen Intern Med 20:1120-6. 2005
    ..The objective of this study was to describe laboratory monitoring among ambulatory patients dispensed medications for which laboratory testing is recommended at therapy initiation...
  51. ncbi request reprint Chronic disease score as a predictor of hospitalization
    Kathleen G Putnam
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Epidemiology 13:340-6. 2002
    ..We compared four versions of the score for their ability to predict hospitalization among members of eight health maintenance organizations nationwide...
  52. ncbi request reprint FDA drug prescribing warnings: is the black box half empty or half full?
    Anita K Wagner
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Pharmacoepidemiol Drug Saf 15:369-86. 2006
    ..The purpose of the present study was to assess the frequency of use of BBW medications in ambulatory care and prescribing compliance with BBW recommendations...
  53. ncbi request reprint Liver function testing in patients on HMG-CoA reductase inhibitors
    Susan E Andrade
    Department of Applied Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA
    Pharmacoepidemiol Drug Saf 12:307-13. 2003
    ..We sought to determine the frequency and patterns of LFT screening in patients receiving HMG-CoA reductase inhibitors...
  54. ncbi request reprint Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much?
    Douglas W Roblin
    Research Department, Kaiser Permanente, Atlanta, Georgia 30305, and the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA
    Med Care 43:951-9. 2005
    ..For patients with a chronic disease, increased cost-sharing for medications may lead to unintended consequences, including reduced use of medications essential for control of their disease...
  55. doi request reprint Hormone therapy initiation after the Women's Health Initiative
    Katherine M Newton
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Menopause 15:487-93. 2008
    ..To describe hormone therapy (HT) initiation after the 2002 publication of the Women's Health Initiative...
  56. ncbi request reprint Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy
    Robert L Davis
    Center for Health Studies, Group Health Cooperative, Seattle, WA, USA
    Pharmacoepidemiol Drug Saf 16:1086-94. 2007
    ..To evaluate risks for perinatal complications and congenital defects among infants exposed in utero to antidepressants...
  57. ncbi request reprint Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit, P O Box 378066, Denver, CO 80237 8066, USA
    J Manag Care Pharm 12:656-64. 2006
    ..Amiodarone can cause liver and thyroid toxicity, but little is known about compliance with laboratory tests to evaluate liver and thyroid function among ambulatory patients who are dispensed amiodarone...
  58. ncbi request reprint Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees
    Steven R Simon
    HMO Research Network Center for Education and Research in Therapeutics and Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    J Am Geriatr Soc 53:2165-9. 2005
    ..To identify correlates of laboratory monitoring errors in elderly health maintenance organization (HMO) members at the initiation of therapy with cardiovascular medications...